PF-06655075 presents a peptide-inspired scaffold with tailored hydrophobic, aromatic, and charged residues supporting high-affinity binding studies. Conformational constraints promote defined secondary structure in solution. Researchers investigate its interactions with protein targets using biophysical and structural methods. Applications span ligand-discovery campaigns, protein-protein interaction modeling, and SAR analysis.
CAT No: R2860
PF-06655075 is a synthetic small molecule compound recognized for its role as a potent and selective inhibitor of receptor-interacting serine/threonine-protein kinase 1 (RIPK1). As a tool compound in biochemical and cell-based research, PF-06655075 enables precise modulation of RIPK1-mediated signaling pathways, which are central to the regulation of necroptosis and inflammatory responses. Its high specificity and favorable pharmacological profile make it a valuable resource for dissecting the molecular mechanisms underlying programmed cell death, inflammation, and related cellular processes. Researchers utilize PF-06655075 to investigate the intricate signaling networks in which RIPK1 is involved, advancing the understanding of cell fate decisions and the broader implications for immunology and cell biology.
Pathway elucidation: PF-06655075 serves as a critical reagent for mapping RIPK1-dependent signaling cascades. By selectively inhibiting RIPK1, investigators can delineate the contributions of this kinase to necroptosis, apoptosis, and inflammatory signaling. The compound is routinely employed in studies aiming to unravel the crosstalk between RIPK1 and other key mediators within the tumor necrosis factor receptor (TNFR) superfamily pathways, providing mechanistic insights into cell death regulation and survival signaling.
Inflammation research: The selective inhibition of RIPK1 by PF-06655075 makes it a preferred tool for exploring the molecular underpinnings of inflammation. Researchers utilize the compound to assess the impact of RIPK1 activity on cytokine production, immune cell activation, and the propagation of inflammatory signals in various in vitro and ex vivo models. Such studies contribute to a deeper understanding of the checkpoints that control inflammatory responses at the cellular and molecular levels.
Cell death mechanism studies: PF-06655075 is widely used to investigate the balance between necroptosis and apoptosis in different cell systems. By blocking RIPK1 activity, scientists can distinguish between caspase-dependent and caspase-independent cell death pathways, enabling the characterization of necroptotic processes in response to diverse stimuli. This application is especially relevant for research focused on the molecular determinants of cell fate, stress responses, and tissue homeostasis.
Target validation: The compound is instrumental in validating RIPK1 as a functional target in a variety of experimental contexts. By employing PF-06655075 in genetic and pharmacological studies, researchers can confirm the specificity and downstream effects of RIPK1 inhibition, thereby strengthening the interpretation of genetic knockdown or knockout models. This approach supports the rigorous evaluation of RIPK1's role in cellular models of disease, injury, and immune regulation.
Chemical biology tool development: PF-06655075 is frequently incorporated into chemical biology workflows aimed at developing new modulators of cell death and inflammation pathways. Its well-characterized selectivity profile and robust cellular activity make it a benchmark inhibitor for comparative studies, assay development, and the screening of novel RIPK1-targeted molecules. The compound thus facilitates the advancement of chemical probe discovery and the refinement of structure-activity relationships within the kinase inhibitor field.
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More